Search

Displaying results 8181 - 8190 of 10000 in total
  1. Drug

    Salirasib

    go.drugbank.com/drugs/DB12681
    Investigational

    Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.

  2. Drug

    UK-432097

    go.drugbank.com/drugs/DB12691
    Investigational

    UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  3. Drug

    DNL343

    go.drugbank.com/drugs/DB18678
    Investigational

    DNL343 is under investigation in clinical trial NCT05842941 (HEALEY ALS Platform Trial - Regimen G DNL343).

  4. Drug

    CVN-424

    go.drugbank.com/drugs/DB18958
    Investigational

    CVN-424 is under investigation in clinical trial NCT06006247 (Early Parkinson's Disease Monotherapy With CVN424).

  5. Drug

    Fialuridine

    go.drugbank.com/drugs/DB15427
    Investigational

    Fialuridine is under investigation in clinical trial NCT01337466 (Biodistribution and Dosimetry Evaluation of [124I]FIAU).

  6. Drug

    Duvoglustat

    go.drugbank.com/drugs/DB03206
    Investigational

    An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.

  7. Drug

    Antipain

    go.drugbank.com/drugs/DB15251
    Experimental

    [A214484, A214487] Antipain was used in 2010 to obtain a crystal structure of the _Leishmania major_ oligopeptidase B (OPB), a serine protease that serves as a virulence factor in trypanosomatids. … [A214481] Early studies investigated the potential for antipain to alter DNA damage and chromosomal aberrations in irradiated cells or those treated with chemical mutagens such as _N_-methyl-_N_'-nitro

  8. Drug

    Galicaftor

    go.drugbank.com/drugs/DB14894
    Investigational

    in Patients With Cystic Fibrosis.). … Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737

  9. Drug

    Nanoparticle Epirubicin

    go.drugbank.com/drugs/DB16248
    Investigational

    Nanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma).

  10. Drug

    KER-047

    go.drugbank.com/drugs/DB19111
    Investigational

    KER-047 is under investigation in clinical trial NCT05927012 (A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (